{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T14:42:50Z","timestamp":1768920170416,"version":"3.49.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,2,7]],"date-time":"2013-02-07T00:00:00Z","timestamp":1360195200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2458-13-117","type":"journal-article","created":{"date-parts":[[2013,2,7]],"date-time":"2013-02-07T17:14:06Z","timestamp":1360257246000},"source":"Crossref","is-referenced-by-count":23,"title":["Rome consensus conference - statement; human papilloma virus diseases in males"],"prefix":"10.1186","volume":"13","author":[{"given":"Andrea","family":"Lenzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Mirone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Bartoletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Ficarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Foresta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Mazzoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saverio G","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Perino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Picardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla Maria","family":"Zotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,7]]},"reference":[{"key":"5285_CR1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/oxfordjournals.epirev.a036020","volume":"10","author":"L Koutsky","year":"1988","unstructured":"Koutsky L, Galloway DA, Holmes KK: Epidemiology of genital human papillomavirus infection. Epidemiol Rev. 1988, 10: 122-163.","journal-title":"Epidemiol Rev"},{"issue":"3","key":"5285_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.gyobfe.2010.01.003","volume":"38","author":"N Gavillon","year":"2010","unstructured":"Gavillon N, Vervaet H, Derniaux E, Terrosi P, Graesslin O, Quereux C: How did I contract human Papillomavirus (HPV)?. Gynecol Obstet Fertil. 2010, 38 (3): 199-204. 10.1016\/j.gyobfe.2010.01.003.","journal-title":"Gynecol Obstet Fertil"},{"issue":"8","key":"5285_CR3","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1086\/507432","volume":"194","author":"EF Dunne","year":"2006","unstructured":"Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR: Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis. 2006, 194 (8): 1044-1057. 10.1086\/507432.","journal-title":"J Infect Dis"},{"issue":"1","key":"5285_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1473-3099(05)70323-6","volume":"6","author":"JM Partridge","year":"2006","unstructured":"Partridge JM, Koutsky LA: Genital human papillomavirus infection in men. Lancet Infect Dis. 2006, 6 (1): 21-31. 10.1016\/S1473-3099(05)70323-6.","journal-title":"Lancet Infect Dis"},{"key":"5285_CR5","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1136\/bmj.323.7308.334","volume":"323","author":"R Harbour","year":"2001","unstructured":"Harbour R, Miller J: A new system for grading recommendations in evidence based guidelines. BMJ. 2001, 323: 334-336.","journal-title":"BMJ"},{"issue":"8","key":"5285_CR6","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1158\/1055-9965.EPI-08-0151","volume":"17","author":"AR Giuliano","year":"2008","unstructured":"Giuliano AR, Lazcano E, Villa LL, Flores R, Salmeron J, Lee JH, Papenfuss MR, Abrahamsen M, Jolles E, Nielson CM, Baggio ML, Silva R, Quiteri M: The Human Papillomavirus Infection in Men (HIM) study: HPV prevalence and type-distribution among men residing in Brazil, Mexico, and the US. Cancer Epidemiol Biomarkers Prev. 2008, 17 (8): 2036-2043. 10.1158\/1055-9965.EPI-08-0151.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"5285_CR7","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1086\/521629","volume":"196","author":"AR Giuliano","year":"2007","unstructured":"Giuliano AR, Nielson CM, Flores R, Dunne EF, Abrahamsen M, Papenfuss MR, et al: The optimal anatomic sites for sampling heterosexual men for human Papillomavirus (HPV) detection: the HPV detection in men study. J Infect Dis. 2007, 196 (8): 1146-1152. 10.1086\/521629.","journal-title":"J Infect Dis"},{"key":"5285_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00007435-199320060-00004","volume":"20","author":"M Hippelainen","year":"1993","unstructured":"Hippelainen M, Syrjanen S, Hippelainen M, et al: Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: a study on Finnish conscripts. Sex Transm Dis. 1993, 20: 321-328. 10.1097\/00007435-199320060-00004.","journal-title":"Sex Transm Dis"},{"issue":"4","key":"5285_CR9","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1086\/381395","volume":"189","author":"BA Weaver","year":"2004","unstructured":"Weaver BA, Feng Q, Holmes KK, Kiviat N, Lee SK, Meyer C, et al: Evaluation of genital sites and sampling techniques for detection of human Papillomavirus DNA in men. J Infect Dis. 2004, 189 (4): 677-685. 10.1086\/381395.","journal-title":"J Infect Dis"},{"key":"5285_CR10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/00007435-200105000-00007","volume":"28","author":"E Lazcano-Ponce","year":"2001","unstructured":"Lazcano-Ponce E, Herrero R, Munoz N, et al: High prevalence of human papillomavirus infection in Mexican males: comparative study of penile-urethral swabs and urine samples. Sex Transm Dis. 2001, 28: 277-280. 10.1097\/00007435-200105000-00007.","journal-title":"Sex Transm Dis"},{"key":"5285_CR11","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1158\/1055-9965.EPI-04-0754","volume":"14","author":"SK Kjaer","year":"2005","unstructured":"Kjaer SK, Munk C, Winther JF, Jorgensen HO, Meijer CJ, van den Brule AJ: Acquisition and persistence of human papillomavirus infection in younger men: a prospective follow-up study among Danish soldiers. Cancer Epidemiol Biomarkers Prev. 2005, 14: 1528-1533. 10.1158\/1055-9965.EPI-04-0754.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5285_CR12","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1158\/1055-9965.EPI-04-0926","volume":"14","author":"M Lajous","year":"2005","unstructured":"Lajous M, Mueller N, Cruz-Valdez A, Aguilar LV, Franceschi S, Hernandez-Avila M: Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men. Cancer Epidemiol Biomarkers Prev. 2005, 14: 1710-1716. 10.1158\/1055-9965.EPI-04-0926.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5285_CR13","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1086\/421279","volume":"190","author":"H-R Shin","year":"2004","unstructured":"Shin H-R, Franceschi S, Vaccarella S, et al: Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. J Infect Dis. 2004, 190: 468-476. 10.1086\/421279.","journal-title":"J Infect Dis"},{"key":"5285_CR14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1258\/0956462001915417","volume":"11","author":"A Wikstrom","year":"2000","unstructured":"Wikstrom A, Popescu C, Forslund O: Asymptomatic penile HPV infection: a prospective study. Int J STD AIDS. 2000, 11: 80-84. 10.1258\/0956462001915417.","journal-title":"Int J STD AIDS"},{"key":"5285_CR15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1136\/sti.78.3.215","volume":"78","author":"EI Svare","year":"2002","unstructured":"Svare EI, Kjaer SK, Worm AM, Osterlind A, Meijer CJ, van den Brule AJ: Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic. Sex Transm Infect. 2002, 78: 215-218. 10.1136\/sti.78.3.215.","journal-title":"Sex Transm Infect"},{"key":"5285_CR16","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1086\/368220","volume":"187","author":"SB Baldwin","year":"2003","unstructured":"Baldwin SB, Wallace DR, Papenfuss MR, et al: Human Papillomavirus infection in men attending a sexually transmitted disease clinic. J Infect Dis. 2003, 187: 1064-1070. 10.1086\/368220.","journal-title":"J Infect Dis"},{"key":"5285_CR17","first-page":"240","volume":"70","author":"GJ Van Doornum","year":"1994","unstructured":"Van Doornum GJ, Prins M, Juffermans LH, et al: Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study. Genitourin Med. 1994, 70: 240-246.","journal-title":"Genitourin Med"},{"key":"5285_CR18","first-page":"76","volume":"21","author":"S Takahashi","year":"2005","unstructured":"Takahashi S, Takeyama K, Miyamoto S, et al: Incidence of sexually transmitted infections in asymptomatic healthy young Japanese men. J Infect Chemother. 2005, 21: 76-82.","journal-title":"J Infect Chemother"},{"key":"5285_CR19","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1067\/mjd.2002.122198","volume":"47","author":"MC Bleeker","year":"2002","unstructured":"Bleeker MC, Hogewoning CJ, Van Den Brule AJ, et al: Penile lesions and human Papillomavirus in male sexual partners of women with cervical intraepithelial neoplasia. J Am Acad Dermatol. 2002, 47: 351-357. 10.1067\/mjd.2002.122198.","journal-title":"J Am Acad Dermatol"},{"key":"5285_CR20","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/sj.bjc.6600194","volume":"86","author":"S Franceschi","year":"2002","unstructured":"Franceschi S, Castellsagu\u00e9 X, Dal Maso L, et al: Prevalence and determinants of human Papillomavirus genital infection in men. Br J Cancer. 2002, 86: 705-711. 10.1038\/sj.bjc.6600194.","journal-title":"Br J Cancer"},{"key":"5285_CR21","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1086\/431978","volume":"41","author":"MC Bleeker","year":"2005","unstructured":"Bleeker MC, Hogewoning CJ, Berkhof J, et al: Concordance of specific human Papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads. Clin Infect Dis. 2005, 41: 612-620. 10.1086\/431978.","journal-title":"Clin Infect Dis"},{"key":"5285_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/00007435-199403000-00004","volume":"21","author":"MI Hippelainen","year":"1994","unstructured":"Hippelainen MI, Yliskoski M, Syrjanen S, et al: Low concordance of genital human Papillomavirus (HPV) lesions and viral types in HPV infected women and their male sexual partners. Sex Transm Dis. 1994, 21: 76-82. 10.1097\/00007435-199403000-00004.","journal-title":"Sex Transm Dis"},{"key":"5285_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.urology.2004.09.031","volume":"65","author":"SM Nicolau","year":"2005","unstructured":"Nicolau SM, Camargo CG, Stavale JN, et al: Human papillomavirus DNA detection in male sexual partners of women with genital human Papillomavirus infection. Urology. 2005, 65: 251-255. 10.1016\/j.urology.2004.09.031.","journal-title":"Urology"},{"issue":"S3","key":"5285_CR24","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1016\/j.vaccine.2006.05.031","volume":"24","author":"AN Burchell","year":"2006","unstructured":"Burchell AN, Winer RL, de Sanjos\u00e9 S, Franco EL: Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine. 2006, 24 (S3): S52-S61.","journal-title":"Vaccine"},{"issue":"2","key":"5285_CR25","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ejca.2004.07.005","volume":"41","author":"G Ronco","year":"2005","unstructured":"Ronco G, Ghisetti V, Segnan N, Snijders PJF, Gillio-Tos A, Meijer CJ, Merletti F, Franceschi S: Prevalence of human papillomavirus infection in women in Turin, Italy. Eur J Cancer. 2005, 41 (2): 297-305. 10.1016\/j.ejca.2004.07.005.","journal-title":"Eur J Cancer"},{"key":"5285_CR26","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1086\/315086","volume":"180","author":"EL Franco","year":"1999","unstructured":"Franco EL, Villa LL, Sobrinho JP, et al: Epidemiology of acquisition and clearance of cervical human Papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis. 1999, 180: 1415-1423. 10.1086\/315086.","journal-title":"J Infect Dis"},{"key":"5285_CR27","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1086\/521192","volume":"196","author":"JM Partridge","year":"2007","unstructured":"Partridge JM, Hughes JP, Feng Q, et al: Genital human Papillomavirus infection in men: incidence and risk factors in a cohort of university students. J Infect Dis. 2007, 196: 1128-1136. 10.1086\/521192.","journal-title":"J Infect Dis"},{"key":"5285_CR28","first-page":"733","volume":"66","author":"B Suligoi","year":"2010","unstructured":"Suligoi B, Salfa MC, Mariani L: Epidemiologia e management dei pazienti con condilomi genitali in Italia. Ig Sanita Pubbl. 2010, 66: 733-756.","journal-title":"Ig Sanita Pubbl"},{"issue":"1","key":"5285_CR29","first-page":"33","volume":"20","author":"G Vittori","year":"2008","unstructured":"Vittori G, Matteolli A, Boselli F, Naldi L, Emberti GL: A new approach to estimate Genital Warts incidence and prevalence in the Italian general female population. It J Gynaecol Obstet. 2008, 20 (1): 33-42.","journal-title":"It J Gynaecol Obstet"},{"key":"5285_CR30","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1365-2605.2010.01075.x","volume":"34","author":"C Foresta","year":"2010","unstructured":"Foresta C, Ferlin A, Bertoldo A, Patassini C, Zuccarello D, Garolla A: Human papilloma virus in the sperm cryobank: an emerging problem?. Int J Androl. 2010, 34: 242-246.","journal-title":"Int J Androl"},{"key":"5285_CR31","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1128\/JCM.01576-06","volume":"45","author":"L Giovannelli","year":"2007","unstructured":"Giovannelli L, Migliore MC, Capra G, Caleca MP, Bellavia C, Perino A, Viviano E, Matranga D, Ammatuna P: Penile, urethral, and seminal sampling for diagnosis of human Papillomavirus infection in men. J Clin Microbiol. 2007, 45: 248-251. 10.1128\/JCM.01576-06.","journal-title":"J Clin Microbiol"},{"key":"5285_CR32","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1442-2042.2010.02521.x","volume":"17","author":"K Shigehara","year":"2010","unstructured":"Shigehara K, Sasagawa T, Kawaguchi S, Kobori Y, Nakashima T, Shimamura M, Taya T, Furubayashi K, Namiki M: Prevalence of human Papillomavirus infection in the urinary tract of men with urethritis. Int J Urol. 2010, 17: 563-569. 10.1111\/j.1442-2042.2010.02521.x.","journal-title":"Int J Urol"},{"key":"5285_CR33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1136\/sti.2008.033068","volume":"85","author":"GS Ogilvie","year":"2009","unstructured":"Ogilvie GS, Taylor DL, Achen M, Cook D, Krajden M: Self-collection of genital human Papillomavirus specimens in heterosexual men. Sex Transm Infect. 2009, 85: 221-225. 10.1136\/sti.2008.033068.","journal-title":"Sex Transm Infect"},{"key":"5285_CR34","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1002\/jmv.21733","volume":"82","author":"L Barzon","year":"2010","unstructured":"Barzon L, Militello V, Pagni S, et al: Distribution of human Papillomavirus types in the anogenital tract of females and males. J Med Virol. 2010, 82: 1424-1430. 10.1002\/jmv.21733.","journal-title":"J Med Virol"},{"key":"5285_CR35","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1258\/0956462042395122","volume":"15","author":"MA Rintala","year":"2004","unstructured":"Rintala MA, Gr\u00e9nman SE, P\u00f6ll\u00e4nen PP, Suominen JJ, Syrj\u00e4nen SM: Detection of high-risk HPV DNA in semen and its association with the quality of semen. Int J STD AIDS. 2004, 15: 740-743. 10.1258\/0956462042395122.","journal-title":"Int J STD AIDS"},{"key":"5285_CR36","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/S0015-0282(97)81454-9","volume":"67","author":"YM Lai","year":"1997","unstructured":"Lai YM, Lee JF, Huang HY, Soong YK, Yang FP, Pao CC: The effect of human Papillomavirus infection on sperm cell motility. Fertil Steril. 1997, 67: 1152-1155. 10.1016\/S0015-0282(97)81454-9.","journal-title":"Fertil Steril"},{"key":"5285_CR37","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0029-7844(00)01183-2","volume":"97","author":"O Olatunbosun","year":"2001","unstructured":"Olatunbosun O, Deneer H, Pierson R: Human Papillomavirus DNA detection in sperm using polymerase chain reaction. Obstet Gynecol. 2001, 97: 357-360. 10.1016\/S0029-7844(00)01183-2.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"5285_CR38","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.fertnstert.2006.01.051","volume":"86","author":"SD Spandorfer","year":"2006","unstructured":"Spandorfer SD, Bongiovanni AM, Fasioulotis S, Rosenwaks Z, Ledger WJ, Witkin SS: Prevalence of cervical human papillomavirus in women undergoing in vitro fertilization and association with outcome. Fertil Steril. 2006, 86 (3): 765-767. 10.1016\/j.fertnstert.2006.01.051.","journal-title":"Fertil Steril"},{"issue":"10","key":"5285_CR39","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1086\/652187","volume":"201","author":"AG Nyitray","year":"2010","unstructured":"Nyitray AG, Smith D, Villa L, et al: Prevalence of and risk factors for anal human Papillomavirus infection in men who have sex with women: a cross-national study. J Infect Dis. 2010, 201 (10): 1498-1508. 10.1086\/652187.","journal-title":"J Infect Dis"},{"issue":"Suppl 4","key":"5285_CR40","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.jadohealth.2010.01.010","volume":"46","author":"JM Palefsky","year":"2010","unstructured":"Palefsky JM: Human Papillomavirus-related disease in men: not just a women\u2019s issue. J Adolesc Health. 2010, 46 (Suppl 4): S12-S19.","journal-title":"J Adolesc Health"},{"key":"5285_CR41","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ejogrb.2006.12.026","volume":"137","author":"PC Giraldo","year":"2008","unstructured":"Giraldo PC, Eleut\u00e9rio J, Cavalcante DI, Gon\u00e7alves AK, Rom\u00e3o JA, Eleut\u00e9rio RM: The role of high-risk HPV-DNA testing in the male sexual partners of women with HPV-induced lesions. Eur J Obstet Gynecol Reprod Biol. 2008, 137: 88-91. 10.1016\/j.ejogrb.2006.12.026.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"Suppl 1","key":"5285_CR42","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/j.jcv.2004.12.004","volume":"32","author":"A Molijn","year":"2005","unstructured":"Molijn A, Kleter B, Quint W, van Doorn LJ: Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol. 2005, 32 (Suppl 1): S43-S51.","journal-title":"J Clin Virol"},{"key":"5285_CR43","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ijc.24770","volume":"126","author":"JS Smith","year":"2010","unstructured":"Smith JS, Backes DM, Hudgens MG, Bailey RC, Veronesi G, Bogaarts M, Agot K, Ndinya-Achola JO, Maclean I, Agingu W, Meijer CJ, Moses S, Snijders PJ: Prevalence and risk factors of human papillomavirus infection by penile site in uncircumcised Kenyan men. Int J Cancer. 2010, 126: 572-577. 10.1002\/ijc.24770.","journal-title":"Int J Cancer"},{"key":"5285_CR44","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/jmv.21732","volume":"82","author":"A Damay","year":"2010","unstructured":"Damay A, Fabre J, Costes V, Didelot JM, Didelot MN, Boulle N, Segondy M: Human Papillomavirus (HPV) prevalence and type distribution, and HPV-associated cytological abnormalities in anal specimens from men infected with HIV who have sex with men. J Med Virol. 2010, 82: 592-596. 10.1002\/jmv.21732.","journal-title":"J Med Virol"},{"key":"5285_CR45","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000214920","volume":"12","author":"H Trottier","year":"2009","unstructured":"Trottier H, Burchell AN: Epidemiology of mucosal human papillomavirus infection and associated diseases. Public Health Genomics. 2009, 12: 291-307. 10.1159\/000214920.","journal-title":"Public Health Genomics"},{"issue":"Suppl 1","key":"5285_CR46","doi-asserted-by":"publisher","first-page":"A17","DOI":"10.1016\/j.vaccine.2008.10.091","volume":"27","author":"E Tanzi","year":"2009","unstructured":"Tanzi E, Amendola A, Bianchi S, Fasolo MM, Beretta R, Pariani E, Zappa A, Frati E, Orlando G: Human Papillomavirus genotypes and phylogenetic analysis of HPV-16 variants in HIV-1 infected subjects in Italy. Vaccine. 2009, 27 (Suppl 1): A17-A23.","journal-title":"Vaccine"},{"key":"5285_CR47","volume-title":"European guidelines for quality assurance in cervical cancer screening","author":"M Arbyn","year":"2008","unstructured":"Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, Wiener HG, Herbert A, Daniel J, von Karsa L: European guidelines for quality assurance in cervical cancer screening. 2008, IARC, The full text is available for download from the IARC\u2019s web site: http:\/\/screening.iarc.fr\/doc\/ND7007117ENC_002.pdf , 2","edition":"2"},{"key":"5285_CR48","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1750-9378-3-14","volume":"3","author":"L Barzon","year":"2008","unstructured":"Barzon L, Giorgi C, Buonaguro FM, Pal\u00f9 G, the Italian Society for Virology: Guidelines of the Italian Society for Virology on HPV testing and vaccination for cervical cancer prevention. Infect Agent Canc. 2008, 3: 14-10.1186\/1750-9378-3-14. The full text is available for download from: http:\/\/www.infectagentscancer.com\/content\/pdf\/1750-9378-3-14.pdf","journal-title":"Infect Agent Canc"},{"key":"5285_CR49","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/aje\/kwf180","volume":"157","author":"RL Winer","year":"2003","unstructured":"Winer RL, Lee SK, Hughes JP, et al: Genital human papillomavirus infection: incidence and risk factors in a cohor of female university students. Am J Epidemiol. 2003, 157: 218-226. 10.1093\/aje\/kwf180.","journal-title":"Am J Epidemiol"},{"key":"5285_CR50","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/jmv.21189","volume":"80","author":"M Benevolo","year":"2008","unstructured":"Benevolo M, Mottolese M, Marandino F, et al: HPV prevalence among healthy italian male sexual partners of women with cervical HPV-infection. J Med Virol. 2008, 80: 1275-1281. 10.1002\/jmv.21189.","journal-title":"J Med Virol"},{"issue":"1","key":"5285_CR51","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/EDE.0b013e3181c1e70b","volume":"21","author":"AN Burchell","year":"2010","unstructured":"Burchell AN, Tellier PP, Hanley J, Coutl\u00e9e F, Franco EL: Human Papillomavirus infections among couples in new sexual relationships. Epidemiology. 2010, 21 (1): 31-37. 10.1097\/EDE.0b013e3181c1e70b.","journal-title":"Epidemiology"},{"key":"5285_CR52","first-page":"201","volume":"89","author":"JJ Goedert","year":"1998","unstructured":"Goedert JJ, Cote TR, Virgo P, et al: Spectrum of AIDS-associated malignant disorders. Lancet. 1998, 89: 201-211.","journal-title":"Lancet"},{"key":"5285_CR53","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1093\/jnci\/88.15.1060","volume":"88","author":"FX Bosch","year":"1996","unstructured":"Bosch FX, Castellsagu\u00e9 X, Munoz N, et al: Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancers in Spain. J Natl Cancer Inst. 1996, 88: 1060-1067. 10.1093\/jnci\/88.15.1060.","journal-title":"J Natl Cancer Inst"},{"key":"5285_CR54","first-page":"101","volume":"10","author":"SK Kjaer","year":"2001","unstructured":"Kjaer SK, Chackerian B, van den Brule AJ, et al: High-risk human papillomavirus is sexually transmitted: evidence from a follow up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev. 2001, 10: 101-106.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5285_CR55","first-page":"1771","volume":"23","author":"I Penn","year":"1991","unstructured":"Penn I: Cancer in the immunosuppressed organ recipient. Transplant Proc. 1991, 23: 1771-1772.","journal-title":"Transplant Proc"},{"key":"5285_CR56","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1097\/00002030-200203290-00014","volume":"16","author":"D Serraino","year":"2002","unstructured":"Serraino D, Dal Maso L, La Vecchia C, Franceschi S: Invasive cervical cancer as an AIDS-defining illness in Europe. AIDS. 2002, 16: 781-786. 10.1097\/00002030-200203290-00014.","journal-title":"AIDS"},{"issue":"1","key":"5285_CR57","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/QAI.0b013e3181b327e7","volume":"53","author":"B Auvert","year":"2010","unstructured":"Auvert B, Lissouba P, Cutler E, Zarca K, Puren A, Taljaard D: Association of oncogenic and nononcogenic human papillomavirus with HIV incidence. J Acquir Immune Defic Syndr. 2010, 53 (1): 111-116. 10.1097\/QAI.0b013e3181b327e7.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"5285_CR58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mrm.20777","volume":"55","author":"CDC","year":"2006","unstructured":"CDC: Sexually transmitted diseases treatment guidelines. MMWR. 2006, 55: 1-94. RR-11","journal-title":"MMWR"},{"issue":"19","key":"5285_CR59","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1056\/NEJMoa061741","volume":"356","author":"Future II Study Group","year":"2007","unstructured":"Future II Study Group: Quadrivalent vaccine against human Papillomavirus to prevent highgrade cervical lesions. N Engl J Med. 2007, 356 (19): 1915-1927.","journal-title":"N Engl J Med"},{"key":"5285_CR60","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/S0140-6736(07)60852-6","volume":"369","author":"KA Ault","year":"2007","unstructured":"Ault KA: Effect of prophylactic human Papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. Lancet. 2007, 369: 1861-1868. 10.1016\/S0140-6736(07)60852-6.","journal-title":"Lancet"},{"issue":"10","key":"5285_CR61","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1158\/1940-6207.CAPR-09-0031","volume":"2","author":"SK Kjaer","year":"2009","unstructured":"Kjaer SK, Sigurdsson K, Iversen OE, et al: A pooled analysis of continued prophylactic efficacy of quadrivalent human Papillomavirus (types 6\/11\/16\/18) vaccine against high-grade cervical and external genital lesions. Canc Prev Res. 2009, 2 (10): 868-878. 10.1158\/1940-6207.CAPR-09-0031.","journal-title":"Canc Prev Res"},{"key":"5285_CR62","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","volume":"374","author":"J Paavonen","year":"2009","unstructured":"Paavonen J, Naud P, Salmer\u00f3n J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, Hedrick J, Jaisamrarn U, Limson G, Garland S, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, Jenkins D, Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G, HPV PATRICIA Study Group: Efficacy of human Papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. 2009, 374: 301-323. 10.1016\/S0140-6736(09)61248-4.","journal-title":"Lancet"},{"key":"5285_CR63","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1056\/NEJMoa061760","volume":"356","author":"SM Garland","year":"2007","unstructured":"Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GW, Ferris DG, Steben M, Bryan J, Taddeo FJ, Railkar R, Esser MT, Sings HL, Nelson M, Boslego J, Sattler C, Barr E, Koutsky LA, Females United to Unilaterally Reduce Endo\/Ectocervical Disease (FUTURE) I Investigators: Quadrivalent vaccine against human Papillomavirus to prevent anogenital diseases. N Engl J Med. 2007, 356: 1928-1943. 10.1056\/NEJMoa061760.","journal-title":"N Engl J Med"},{"key":"5285_CR64","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/S0140-6736(07)60777-6","volume":"369","author":"EA Joura","year":"2007","unstructured":"Joura EA, Leodolter S, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA, Garland SM, Harper DM, Tang GW, Ferris DG, Steben M, Jones RW, Bryan J, Taddeo FJ, Bautista OM, Esser MT, Sings HL, Nelson M, Boslego JW, Sattler C, Barr E, Paavonen J: Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulvar and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet. 2007, 369: 1693-1702. 10.1016\/S0140-6736(07)60777-6.","journal-title":"Lancet"},{"key":"5285_CR65","doi-asserted-by":"publisher","first-page":"c3493","DOI":"10.1136\/bmj.c3493","volume":"340","author":"The Future I\/II Study Group","year":"2010","unstructured":"The Future I\/II Study Group: Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ. 2010, 340: c3493-10.1136\/bmj.c3493.","journal-title":"BMJ"},{"key":"5285_CR66","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/S0140-6736(09)60691-7","volume":"373","author":"N Mu\u00f1oz","year":"2009","unstructured":"Mu\u00f1oz N, Manalastas R, Pitisuttithum P, et al: Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24\u201345\u2009years: a randomised, double-blind trial. Lancet. 2009, 373: 1949-1957. 10.1016\/S0140-6736(09)60691-7.","journal-title":"Lancet"},{"key":"5285_CR67","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1056\/NEJMoa0909537","volume":"364","author":"AR Giuliano","year":"2011","unstructured":"Giuliano AR, Palefsky JM, Goldstone S, Moreira ED, Penny ME, Aranda C, Vardas E, Moi H, Jessen H, Hillman R, Chang YH, Ferris D, Rouleau D, Bryan J, Marshall JB, Vuocolo S, Barr E, Radley D, Haupt RM, Guris D: Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med. 2011, 364: 401-411. 10.1056\/NEJMoa0909537.","journal-title":"N Engl J Med"},{"key":"5285_CR68","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/jnci\/85.1.19","volume":"85","author":"C Maden","year":"1993","unstructured":"Maden C, Sherman KJ, Beckmann AM, Hislop TG, Teh CZ, Ashley RL, et al: History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst. 1993, 85: 19-24. 10.1093\/jnci\/85.1.19.","journal-title":"J Natl Cancer Inst"},{"key":"5285_CR69","unstructured":"European Commission, Directorate General for Health and Consumers, Public Health: Gardasil, summary of product characteristics. Full text available for download from the European Commission\u2019s web site: http:\/\/ec.europa.eu\/health\/documents\/community-register\/2011\/20110801107489\/anx_107489_en.pdf"},{"issue":"20","key":"5285_CR70","first-page":"630","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","unstructured":"Centers for Disease Control and Prevention (CDC): Morbidity and Mortality Weekly Report (MMWR). FDA Licensure of Quadrivalent Human Papillomavirus Vaccine (HPV 4, Gardasil) for Use in Males and Guidance from the Advisory Committee on Immunization Practices (ACIP). 2010, 59 (20): 630-632. http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm5920a5.htm?s_cid=mm5920a5_e ,","journal-title":"FDA Licensure of Quadrivalent Human Papillomavirus Vaccine (HPV 4, Gardasil) for Use in Males and Guidance from the Advisory Committee on Immunization Practices (ACIP)"},{"key":"5285_CR71","volume-title":"Efficacy of the quadrivalent HPV vaccine to prevent anal intraepithelial neoplasia among young men who have sex with men. 26th International Papillomavirus Conference (IPC)","author":"J Palefsky","year":"2010","unstructured":"Palefsky J: Efficacy of the quadrivalent HPV vaccine to prevent anal intraepithelial neoplasia among young men who have sex with men. 26th International Papillomavirus Conference (IPC). 2010, Montr\u00e9al, Canada, Abstract available for download from the IPC\u2019s web site: http:\/\/hpv2010.org\/main\/images\/stories\/hpv2010_abstracts.pdf"},{"key":"5285_CR72","volume-title":"A case assignment methodology for determining qHPV vaccine efficacy against anal intraepithelial neoplasia. 26th International Papillomavirus Conference (IPC)","author":"S Goldstone","year":"2010","unstructured":"Goldstone S: A case assignment methodology for determining qHPV vaccine efficacy against anal intraepithelial neoplasia. 26th International Papillomavirus Conference (IPC). 2010, Montr\u00e9al, Canada, Abstract (P-597) available for download from the IPC\u2019s web site: http:\/\/hpv2010.org\/main\/images\/stories\/hpv2010_abstracts.pdf"},{"key":"5285_CR73","unstructured":"Food and Drug Administration (FDA): FDA news release. Gardasil approved to prevent anal cancer. Full text available for download from the FDA\u2019s web site: http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm237941.htm"},{"key":"5285_CR74","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/ijc.11474","volume":"107","author":"CJ Hogewoning","year":"2003","unstructured":"Hogewoning CJ, Bleeker MC, van den Brule AJ, et al: Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human Papillomavirus: a randomized clinical trial. Int J Cancer. 2003, 107: 811-816. 10.1002\/ijc.11474.","journal-title":"Int J Cancer"},{"key":"5285_CR75","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1086\/521632","volume":"196","author":"CM Nielson","year":"2007","unstructured":"Nielson CM, Harris RB, Dunne EF, Abrahamsen M, Papenfuss MR, Flores R, Markowitz LE, Giuliano AR: Risk factors for anogenital human Papillomavirus infection in men. J Infect Dis. 2007, 196: 1137-1145. 10.1086\/521632.","journal-title":"J Infect Dis"},{"key":"5285_CR76","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/sti.2009.037788","volume":"85","author":"CK Fairley","year":"2009","unstructured":"Fairley CK, Hocking JS, Gurrin LC, Chen MY, Donovan B, Bradshaw CS: Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women. Sex Transm Infect. 2009, 85: 499-502. 10.1136\/sti.2009.037788.","journal-title":"Sex Transm Infect"},{"key":"5285_CR77","volume-title":"Overview of cost-effectiveness of male HPV vaccination","author":"H Chesson","year":"2009","unstructured":"Chesson H: Overview of cost-effectiveness of male HPV vaccination. 2009, Centers for Disease Control (CDC) and Prevention Advisory Committee on Immunization Practices, Full text available for download from the CDC\u2019s web site: http:\/\/www.cdc.gov\/vaccines\/recs\/acip\/downloads\/min-oct09.pdf"},{"key":"5285_CR78","volume-title":"Quadrivalent HPV vaccine for males: future considerations","author":"L Markowitz","year":"2010","unstructured":"Markowitz L: Quadrivalent HPV vaccine for males: future considerations. 2010, Centers for Disease Control (CDC) and Prevention Advisory Committee on Immunization Practices, Full text available for download from the CDC\u2019s web site: http:\/\/www.cdc.gov\/vaccines\/recs\/acip\/downloads\/min-feb10.pdf"},{"issue":"suppl 3 S3\/","key":"5285_CR79","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.vaccine.2006.05.116","volume":"24","author":"GP Garnett","year":"2006","unstructured":"Garnett GP, Kim JJ, French K, Goldie SJ: Modelling the impact of HPV vaccines on cervical cancer and screening programmes. Vaccine. 2006, 24 (suppl 3 S3\/): 178-186.","journal-title":"Vaccine"},{"key":"5285_CR80","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S0140-6736(07)60475-9","volume":"369","author":"L Udesky","year":"2007","unstructured":"Udesky L: Push to mandate HPV vaccine triggers backlash in USA. Lancet. 2007, 369: 979-980. 10.1016\/S0140-6736(07)60475-9. CrossRef][Web of Science][Medline]","journal-title":"Lancet"},{"key":"5285_CR81","first-page":"69","volume":"75","author":"SE Robertson","year":"1997","unstructured":"Robertson SE, Cutts FT, Samuel R, Diaz-Ortega JL: Control of rubella and congenital rubella syndrome (CRS) in developing countries. Part 2: vaccination against rubella. Bull World Health Organ. 1997, 75: 69-80.","journal-title":"Bull World Health Organ"},{"key":"5285_CR82","volume-title":"Ricognizione delle decisioni regionali in merito alla vaccinazione anti-HPV e primi dati di copertura vaccinale a fine anno","author":"C Giambi","year":"2009","unstructured":"Giambi C, National Institute of Health - Istituto Superiore di Sanit\u00e0. CNEPS, Centro Nazionale di Epidemiologia, Sorveglianza e Promozione della Salute: Ricognizione delle decisioni regionali in merito alla vaccinazione anti-HPV e primi dati di copertura vaccinale a fine anno. 2009, Full text available for download from the NIH\u2019s web site: http:\/\/www.epicentro.iss.it\/focus\/hpv\/pdf\/HPV-2009.pdf"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-13-117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-13-117\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-13-117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T11:52:00Z","timestamp":1562673120000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-13-117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,7]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["5285"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-13-117","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,7]]},"article-number":"117"}}